Classical Prognostic Factors for Survival and Loco-Regional Control in Breast Cancer Patients Treated with Radical Mastectomy Alone

References

• Cutler S J, Ederer F. Maximum utilisation of the life table method in analysing survival. J Chronic Dis 1958; 8: 699–713
   PubMedGoogle Scholar
• Peto R, Pike M C, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 1977; 35: 139
   Google Scholar
• Cox R D. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187–220
   Web of Science ®Google Scholar
• Carter C L, Allen C, Heuson D. Relation of tumour size, lymph node status and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181–7
   PubMed Web of Science ®Google Scholar
• Fisher B, Bauer M, Wickerham D L, Redmond C K, Fisher E R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551–7
   PubMed Web of Science ®Google Scholar
• Fisher E R, Constantino J, Fisher B, Redmond C. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) Discriminants for 15 year survival. Cancer 1993; 71: 2141–50
   PubMed Web of Science ®Google Scholar
• Mouridsen H T, Andersen J, Andersen K W, et al. Classical prognostic factors in node negative breast cancer. J Natl Cancer Inst Monogr 1992; 11: 116–66
   Google Scholar
• Wilking N, Rutquist L E, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol 1992; 31: 29–35
   PubMed Web of Science ®Google Scholar
• Easson E C. Postoperative radiotherapy in breast cancer. Prognostic factors in breast cancer, A PM Forrest, P B Kunkler. Livingstone Ltd., Edinburgh, London 1968; 118–27
   Google Scholar
• Rutquist L E, Patterson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomised clinical trial. Radiother Oncol 1993; 26: 104–10
   PubMed Web of Science ®Google Scholar
• Fletcher G H, Montague E D, White E C. Evaluation of irradiation to peripheral lymphatics in conjunction with radical mastectomy for cancer of breast. Cancer 1968; 21: 791–9
   PubMed Web of Science ®Google Scholar
• Chu F CH, Fang Ling Kim JH, Hum S H, Garmatic C J. Locally recurrent carcinoma of the breast. Cancer 1976; 37: 2677–81
   PubMed Web of Science ®Google Scholar
• Haagensen C D. Disease of the breast, 2nd edn. WB Saunders Co., Philadelphia 1971; 706–11
   Google Scholar
• Montague E D, Fletcher G H. Locoregional effectiveness of surgery and radiation therapy in the treatment of breast cancer. Cancer 1985; 55: 2266–72
   PubMed Web of Science ®Google Scholar
• Spratt J S. Locally recurrent cancer after radical mastectomy. Cancer 1967; 20: 1051–3
   PubMed Web of Science ®Google Scholar
• Donegan W L, Perez-Mesa C M, Watson F R. A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 1966; 122: 529–40
   PubMedGoogle Scholar
• Tubiana M, Sarrazin D. The role of postoperative radiotherapy in breast cancer. Breast cancer. Diagnosis and treatment, I M Ariel, J B Cleary. McGraw-Hill, New York 1987; 280–9
   Google Scholar
• Bonadonna G, Valagussa P, Tancini G, et al. Current status of Milan trial for node positive and node negative breast cancer. J Natl Cancer Inst Monogr 1986; 1: 45–9
   Google Scholar
• Fowble B, Glick J, Goodman R. Radiotherapy for the prevention of locoregional recurrence in high risk patients post-mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 1988; 15: 627–31
   PubMed Web of Science ®Google Scholar
• Griem K L, Henderson I C, Gelman R, et al. The 5-year results of a randomised trial of adjuvant radiation therapy after chemotherapy in breast cancer treated with mastectomy. J Clin Oncol 1987; 5: 1546–55
   PubMed Web of Science ®Google Scholar
• Overgaard M, Christensen J, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report from The Danish Breast Cancer Cooperative Group (DBCG 82) trial. Int J Radiat Oncol Biol Phys 1990; 19: 1121–4
   PubMed Web of Science ®Google Scholar
• Haybittle J K, Blamay R W, Elston C W, et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361–5
   PubMed Web of Science ®Google Scholar
• Todd J H, Domle D, Williams M R, et al. Confirmation of a prognostic index primary breast cancer. Br J Cancer 1987; 56: 487–92
   Web of Science ®Google Scholar
• Joensuu H, Toikkanen S. Identification of subgroups with favourable prognosis in breast cancer. Acta Oncol 1992; 31: 293–301
   PubMed Web of Science ®Google Scholar
• Rosen P P, Groshen S, Kinne D W. Survival and prognostic factors in node negative breast cancer: results of long term follow-up studies. J Natl Cancer Inst Monogr 1992; 11: 151–8
   Google Scholar
• Joensuu H, Toikkanen S. Prognosis of breast cancer with small primary tumour (pT1). Acta Oncol 1991; 30: 793–6
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Fisher E R, Caplan R. Relative worth of oestrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast Project Protocol B-06. J Clin Oncol 1988; 6: 1076–7
   PubMed Web of Science ®Google Scholar
• Fisher E R, Redmond C, Fisher B. Prognostic factors in NSABP studies of women with node negative breast cancer. J Natl Cancer Inst Monogr 1992; 11: 151–8
   PubMedGoogle Scholar
• McGuire W L, Tandom A K, Alfred D C, Chamness G C, Clark G M. Commentaries: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 1990; 82: 1006–15
   PubMed Web of Science ®Google Scholar
• Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D, Rousse J. The importance of histologic grading in long-term prognosis of breast cancer: a study of 1010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 1987; 5: 1378–86
   PubMed Web of Science ®Google Scholar
• Gilchrist K W, Kalish L, Gould V E, et al. Interobserver reproducibility of histopathologic features in stage II breast cancer. Breast Cancer Res Treat 1985; 5: 3–10
   PubMed Web of Science ®Google Scholar